Ad-Solid
is a long term investment program that offers lucrative and profitable services
in the advertising industry. Simply put, they help in the promotion of your
products or services in the online industry. Earn and at the same time advertise either your real-life
businesses, other online investment programs, etc. using their advanced
marketing tools by simply purchasing 50 advertisement credits per $1.
Like the rest of the other
long term investment programs in the industry, Ad-Solid
also has a principal return feature which
allows you to receive back your investments after end of term. It also has the compounding
feature from 0-100% allowing you to automatically deposit a fraction or entire
amount of your daily earnings. Upon end of term, the compounded amount plus
your initial investments with then be received as a lump-sum.
Ad-Solid offers a total
of 5 long term investment plans that
allows you to earn for 150 business days
and varies depending on the amount you have invested:
a) Gold – offers 1.2% daily interest rate on invested amounts from $10 - $499.99.
b) Emerald – offers 1.3% daily interest rate on invested amounts from $500 - $1,999.99.
c) Sapphire – offers 1.4% daily interest rate on invested amounts from $2,000 - $4,999.99.
d) Ruby – offers 1.7% daily interest rate on invested amounts from $5,000 - $24,999.99.
e) Diamond – offers 2.1% daily interest rate on invested amounts from $25,000 - $50,000.00.
Having an incredible
well-built, attractive and detailed website design, Ad-Solid will definitely be
a program that is going to draw in the eyes of the many – not only in the HYIP
industry but even beyond. Will it be the next “BIG THING” of 2013, this we do
not know yet but we will wait and see. After all, it is still January!
You can check out Ad-Solid here and do not forget to sign up using my referral link to avail for
the REFERRAL COMMISSION BACK
program. This will allow you to receive the commissioned amounts of your
deposits from me.
READ THE DETAILED PROGRAM REVIEW OF AD-SOLIDS LATER...
No comments:
Post a Comment